Aptevo Therapeutics (APVO) Return on Capital Employed [ROCE] (2016 - 2026)
Aptevo Therapeutics (APVO) recorded Return on Capital Employed [ROCE] of -223.63% in Q2 2026, up 119.02 percentage points from -342.65% a year earlier but down 81.68 percentage points from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2025, Aptevo Therapeutics reported Return on Capital Employed [ROCE] of -171.50%, up 4.11 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a five-year change of -100.89 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -175.61% in FY2024 (-46.14 pp), -129.47% in FY2023 (-51.44 pp), -78.04% in FY2022 (+27.29 pp) and -105.33% in FY2021 (-34.72 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -366.61% in Q1 2025 to -62.77% in Q2 2022 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of +7.86 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 224.66 percentage points in Q1 2026, against a drop of 178.45 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -141.95% (Q1 2026), -125.03% (Q4 2025) and -170.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | -223.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -223.63% |
| Mar 31, 2026 | -141.95% |
| Dec 31, 2025 | -125.03% |
| Sep 30, 2025 | -170.09% |
| Jun 30, 2025 | -342.65% |
| Mar 31, 2025 | -366.61% |
| Dec 31, 2024 | -268.54% |
| Sep 30, 2024 | -268.85% |
| Jun 30, 2024 | -239.06% |
| Mar 31, 2024 | -188.16% |
| Dec 31, 2023 | -153.93% |
| Sep 30, 2023 | -142.46% |
| Jun 30, 2023 | -125.46% |
| Mar 31, 2023 | -106.91% |
| Dec 31, 2022 | -118.11% |
| Sep 30, 2022 | -91.03% |
| Jun 30, 2022 | -62.77% |
| Mar 31, 2022 | -74.43% |
| Dec 31, 2021 | -83.77% |
| Sep 30, 2021 | -68.38% |
API Access
Aptevo Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();